SlideShare a Scribd company logo
Alcohol Policy Network in Europe (APN)
Symposium, 22nd June 2023, Vilnius, Lithuania
WHO/EU Evidence into Action Alcohol Project (EVID-ACTION): Update
Dr Eric Carlin, WHO Regional Office for Europe
• Focus on reducing alcohol consumption and
harms
• Includes 10% APC reduction by 2025, with at least
35 Member States being below baseline of 2010.
There is no safe level of alcohol consumption
for cancer risk
Half of all alcohol- attributable cancers are
NOT because of heavy drinking + so is the
majority of breast cancers. 3
WHO/EU Evidence into Action Alcohol Project (EVID-ACTION)
Source: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/total-(recorded-unrecorded)-alcohol-per-capita-(15-)-consumption (2019 data)
0,0
2,0
4,0
6,0
8,0
10,0
12,0
14,0
16,0
18,0
W
o
r
l
d
N
o
r
w
a
y
G
r
e
e
c
e
I
t
a
l
y
C
y
p
r
u
s
I
c
e
l
a
n
d
M
a
l
t
a
C
r
o
a
t
i
a
U
k
r
a
i
n
e
F
i
n
l
a
n
d
W
H
O
E
u
r
o
p
e
r
e
g
i
o
n
S
w
e
d
e
n
N
e
t
h
e
r
l
a
n
d
s
D
e
n
m
a
r
k
B
e
l
g
i
u
m
P
o
r
t
u
g
a
l
S
l
o
v
a
k
i
a
H
u
n
g
a
r
y
S
p
a
i
n
E
U
2
7
S
l
o
v
e
n
i
a
E
s
t
o
n
i
a
F
r
a
n
c
e
L
u
x
e
m
b
o
u
r
g
P
o
l
a
n
d
I
r
e
l
a
n
d
L
i
t
h
u
a
n
i
a
B
u
l
g
a
r
i
a
A
u
s
t
r
i
a
G
e
r
m
a
n
y
L
a
t
v
i
a
C
z
e
c
h
i
a
R
o
m
a
n
i
a
Annually, every adult (15+) in the EU drinks 11 litres of pure alcohol
Out of the top 10 countries with highest drinking levels: 7 are in the EU
Source: Source: own calculations, based on Rumgay et al., 2021; Sung et al., 2021.
Alcohol-attributable cancer cases (lighter colours) and deaths (darker colours) in the EU, by sex and cancer type, 2020.
Alcohol-attributable cancer cases and deaths in the EU
In the EU, 3 out of
10 deaths from alcohol-
attributable causes were
due to alcohol-
attributable cancers
(2019 data).
Official launch of WHO/EU
Evidence into Action Alcohol
Project (EVID-ACTION) and
meeting of EVID-ACTION Focal
Point Network on Alcohol
6 – 7 December 2022, Copenhagen
EC APN 22 6 23.pdf
Alcohol Health Warnings
Capacity Building, Health
Literacy, Public Knowledge
and Advocacy
Screening and Brief
Interventions
Evidence
and Tools
for Action
WHO EU
Member
States’ Focal
point on
Alcohol
Alcohol
Action
Networks
Training
Alcohol
Health
Warnings
Screening
and Brief
interventions
Public
information
EU Member
States, Iceland,
Norway and
Ukraine
WHO/EU Evidence into Action
Alcohol Project (EVID-ACTION)
WHO/EU Evidence into
Action Alcohol Project
(EVID-ACTION):
Expected results
a) Improved technical capabilities
Higher levels of awareness
Increased support for evidence-
based policies
b) Training packages on
implementation of brief
interventions
c) Strengthened capacity to apply
innovative methods in alcohol health
promotion activities
Specific objective
(SO) one:
Health warnings
Develop the evidence base on alcohol
health warnings, with a specific focus
on cancer risks, to inform the design and
development and implementation of
impactful alcohol health warnings.
SO1: Alcohol health
warnings: Activities to
date & planned
Establishment of
Technical Advisory
Group (TAG)
20 experts worldwide, 1st meeting Dec 2022, 2nd, online meeting Feb and March 2023, next meeting planned Q3 2023
Establishing working groups in the TAG, e.g. working group on legal experts
Experiments Online experiment investigating impact of (cancer) warnings on attention, knowledge, risk perceptions and intentions.
Dissemination in 14 EU countries, 19000+ responses
First protocol draft of an exploratory eye-tracking study on the impact of label design on attention
Co-creation
workshops
Pilot workshops in Ireland in Dec 2022, involving different population groups
Further consultations in association with the established networks
Real-world studies Pilot study with WHO CC in Barcelona: point of sale labels with general health harm message and QR code to investigate
number of shoppers using it to look for the information online
Establishment of collaboration initiative with Nordic countries for further studies on impact of health messages and QR code
use in Nordic monopolies
Publications Producing draft report describing findings of the online experiment and pilot studies
Producing several peer-reviewed articles based on the conducted reviews and the experimental evidence
EC APN 22 6 23.pdf
What is the reach of QR codes as
sources of product information for
alcoholic beverages?
Pilot study: Barcelona
Setting: Supermarket
Information via: Point of sale
Information
components:
“Alcohol harms your health”
For more information see QR code
Result:
Less than 1 per mille of paying
costumers assessed website via QR
code
Conclusion: Providing QR via point of sale will likely
not lead to high reach of consumers
Source: Rehm et al., 2023
https://onlinelibrary.wiley.com/doi/10.1111/dar.13676
Specific objective
(SO) two:
Capacity building, Health
literacy, public knowledge
and advocacy
• Strengthening expertise and sharing
of experience
• Supporting Member States’
resilience in protecting public health
interests in relation to alcohol policies
• National and transnational regulatory
collaboration
• Public communications about alcohol
consumption and cancer risks and
policy options.
Training session for EVID-ACTION Member states on how
to recognize and manage Conflicts of Interest,
Copenhagen, 7th December 2022
Professor Jeff Collin, Professor of Global Health
Policy, Global Health Policy Unit, University of
Edinburgh
Dr Nason Maani, Lecturer in Inequalities and
Global Health Policy, Global Health Policy Unit,
University of Edinburgh
WHO/EU
Evidence into Action Alcohol Project
(EVID-ACTION)
Early career researcher seminar
on alcohol and public health,
Tallinn, 14-15 May 2023
EC APN 22 6 23.pdf
Baltic Alcohol
Control Dialogues
Tallinn, 16-17 May 2023
EC APN 22 6 23.pdf
Training session for EVID-ACTION Member
States representatives in alcohol
epidemiology: what are the key indicators
and how to collect and manage these?
Tallinn, 18 May 2023
EC APN 22 6 23.pdf
Intersectoral health
tax workshop
Tallinn, 19 May 2023
EC APN 22 6 23.pdf
EC APN 22 6 23.pdf
Specific objective
(SO) three
Screening and
Brief Interventions
(SBIs)
• Provide technical tools and training
to support implementation of
evidence-based screening and brief
interventions in:
• Primary healthcare
• Workplace
• Social services
• Assess and map existing resources
and tools
Intercountry expert consultation on
brief interventions (BRIEF),
Barcelona, 24th – 26th April 2023
1) Raising EU visibility and
promoting the collaboration
of WHO and the EU
2) Raising Awareness
3) Changing perceptions
Target audiences
Communications
Objectives
Project
partners
Decision
makers
Narrative
shapers
EU, DG Sante, WHO HQ,
UN Organizations, NGOs
Member States,
health, social protection, finance
ministries, policy advisors in
government
civil society organizations, youth
organizations, academics; health system
stakeholders, country experts, public
health influencers and influential media.
Clear and comprehensive messages targeted at the general
public and tailored to:
WHO/EU Evidence into Action Alcohol Project
(EVID-ACTION)
‘Disrupting narratives on alcohol’:
Expert workshop on communications
Copenhagen, 30th March 2023
Stockholm, 3rd –
12th May 2023
Some of the planned activities coming up later in 2023:
Vilnius:
22nd June, Alcohol Policy Network
23rd June, EUCAM Digital Marketing Conference
24th June WHO Expert meeting on Alcohol Digital Marketing also
with support of Government of Netherlands)
Barcelona:
11th – 13th September, Research conference, including
Early Career Researchers meeting
Brussels:
7th – 8th October, 1st Meeting EVID-ACTION Youth Network
9th – 10th October, EVID-ACTION Member States Focal Point
meeting
11th October, Launch of WHO Alcohol Playbook
November: Activities related to European Awareness Week on
Alcohol- Related harms
Thank you!
32
http://www.euro.who.int/alcohol

More Related Content

Similar to EC APN 22 6 23.pdf

Towards a more equitable, healthier and more sustainable Europe
Towards a more equitable, healthier and more sustainable EuropeTowards a more equitable, healthier and more sustainable Europe
Towards a more equitable, healthier and more sustainable Europe
WHO Regional Office for Europe
 
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Martin Pan
 
HCF 2016: Erika Kunz
HCF 2016: Erika KunzHCF 2016: Erika Kunz
HCF 2016: Erika Kunz
Chemicals Forum Association
 
Webinar SumaSalut - Alcohol i càncer: estat de l’evidència. 10 de juny de 202...
Webinar SumaSalut - Alcohol i càncer: estat de l’evidència. 10 de juny de 202...Webinar SumaSalut - Alcohol i càncer: estat de l’evidència. 10 de juny de 202...
Webinar SumaSalut - Alcohol i càncer: estat de l’evidència. 10 de juny de 202...
PonenciesASPCAT
 
Feeding knowlegde pre meeting
Feeding knowlegde pre meetingFeeding knowlegde pre meeting
Feeding knowlegde pre meeting
adminmetid
 
Tackling societal challenges through digital transformation
Tackling societal challenges through digital transformationTackling societal challenges through digital transformation
Tackling societal challenges through digital transformation
Games for Health Europe
 
DrugInfo seminar: Information and communication technologies in reducing AOD ...
DrugInfo seminar: Information and communication technologies in reducing AOD ...DrugInfo seminar: Information and communication technologies in reducing AOD ...
DrugInfo seminar: Information and communication technologies in reducing AOD ...
Australian Drug Foundation
 
Matt Bolz-Johnson: Rare Drug Strategy Webinar
Matt Bolz-Johnson: Rare Drug Strategy Webinar Matt Bolz-Johnson: Rare Drug Strategy Webinar
Matt Bolz-Johnson: Rare Drug Strategy Webinar
Canadian Organization for Rare Disorders
 
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
EU_CHRODIS
 
Report on future policies and regulatory frameworks
Report on future policies and regulatory frameworksReport on future policies and regulatory frameworks
Report on future policies and regulatory frameworks
Oles Kulchytskyy
 
COPOLAD AT A GLANCE_EN
COPOLAD AT A GLANCE_ENCOPOLAD AT A GLANCE_EN
COPOLAD AT A GLANCE_EN
TERESA SALVADOR-LLIVINA
 
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvisTue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
3GDR
 
Report on current policies and regulatory frameworks
Report on current policies and regulatory frameworksReport on current policies and regulatory frameworks
Report on current policies and regulatory frameworks
Oles Kulchytskyy
 
Eu legislation framework on e health s.stefanelli
Eu legislation framework on e health s.stefanelliEu legislation framework on e health s.stefanelli
Eu legislation framework on e health s.stefanelli
STEFANELLI&STEFANELLI LAW FIRM
 
UK Digital Medicine Research Centre Strategic Development Plan
UK Digital Medicine Research Centre Strategic Development PlanUK Digital Medicine Research Centre Strategic Development Plan
UK Digital Medicine Research Centre Strategic Development Plan
David Wortley
 
Loukianos Gatzoulis EU #MWC14 #mHealth
Loukianos Gatzoulis EU #MWC14 #mHealthLoukianos Gatzoulis EU #MWC14 #mHealth
Loukianos Gatzoulis EU #MWC14 #mHealth
3GDR
 
Guidelines on the Prevention of Toxic Exposures
Guidelines on the Prevention of Toxic Exposures Guidelines on the Prevention of Toxic Exposures
Guidelines on the Prevention of Toxic Exposures
v2zq
 
Implementation of the United Nations Political Declaration on Prevention and ...
Implementation of the United Nations Political Declaration on Prevention and ...Implementation of the United Nations Political Declaration on Prevention and ...
Implementation of the United Nations Political Declaration on Prevention and ...
WHO Regional Office for the Eastern Mediterranean
 
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
Dr Lendy Spires
 
WHO European Action Plan for the Prevention and Control of Noncommunicable Di...
WHO European Action Plan for the Prevention and Control of Noncommunicable Di...WHO European Action Plan for the Prevention and Control of Noncommunicable Di...
WHO European Action Plan for the Prevention and Control of Noncommunicable Di...
WHO Regional Office for Europe
 

Similar to EC APN 22 6 23.pdf (20)

Towards a more equitable, healthier and more sustainable Europe
Towards a more equitable, healthier and more sustainable EuropeTowards a more equitable, healthier and more sustainable Europe
Towards a more equitable, healthier and more sustainable Europe
 
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
Real World Outcomes Across the AD (Alzheimer’s disease) Spectrum (ROADS) to B...
 
HCF 2016: Erika Kunz
HCF 2016: Erika KunzHCF 2016: Erika Kunz
HCF 2016: Erika Kunz
 
Webinar SumaSalut - Alcohol i càncer: estat de l’evidència. 10 de juny de 202...
Webinar SumaSalut - Alcohol i càncer: estat de l’evidència. 10 de juny de 202...Webinar SumaSalut - Alcohol i càncer: estat de l’evidència. 10 de juny de 202...
Webinar SumaSalut - Alcohol i càncer: estat de l’evidència. 10 de juny de 202...
 
Feeding knowlegde pre meeting
Feeding knowlegde pre meetingFeeding knowlegde pre meeting
Feeding knowlegde pre meeting
 
Tackling societal challenges through digital transformation
Tackling societal challenges through digital transformationTackling societal challenges through digital transformation
Tackling societal challenges through digital transformation
 
DrugInfo seminar: Information and communication technologies in reducing AOD ...
DrugInfo seminar: Information and communication technologies in reducing AOD ...DrugInfo seminar: Information and communication technologies in reducing AOD ...
DrugInfo seminar: Information and communication technologies in reducing AOD ...
 
Matt Bolz-Johnson: Rare Drug Strategy Webinar
Matt Bolz-Johnson: Rare Drug Strategy Webinar Matt Bolz-Johnson: Rare Drug Strategy Webinar
Matt Bolz-Johnson: Rare Drug Strategy Webinar
 
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
 
Report on future policies and regulatory frameworks
Report on future policies and regulatory frameworksReport on future policies and regulatory frameworks
Report on future policies and regulatory frameworks
 
COPOLAD AT A GLANCE_EN
COPOLAD AT A GLANCE_ENCOPOLAD AT A GLANCE_EN
COPOLAD AT A GLANCE_EN
 
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvisTue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
Tue 14 jun 09 40 opening address - digital agenda peteris zilgalvis
 
Report on current policies and regulatory frameworks
Report on current policies and regulatory frameworksReport on current policies and regulatory frameworks
Report on current policies and regulatory frameworks
 
Eu legislation framework on e health s.stefanelli
Eu legislation framework on e health s.stefanelliEu legislation framework on e health s.stefanelli
Eu legislation framework on e health s.stefanelli
 
UK Digital Medicine Research Centre Strategic Development Plan
UK Digital Medicine Research Centre Strategic Development PlanUK Digital Medicine Research Centre Strategic Development Plan
UK Digital Medicine Research Centre Strategic Development Plan
 
Loukianos Gatzoulis EU #MWC14 #mHealth
Loukianos Gatzoulis EU #MWC14 #mHealthLoukianos Gatzoulis EU #MWC14 #mHealth
Loukianos Gatzoulis EU #MWC14 #mHealth
 
Guidelines on the Prevention of Toxic Exposures
Guidelines on the Prevention of Toxic Exposures Guidelines on the Prevention of Toxic Exposures
Guidelines on the Prevention of Toxic Exposures
 
Implementation of the United Nations Political Declaration on Prevention and ...
Implementation of the United Nations Political Declaration on Prevention and ...Implementation of the United Nations Political Declaration on Prevention and ...
Implementation of the United Nations Political Declaration on Prevention and ...
 
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
eHealth Tools & Services: Needs of the Member States Report of the WHO Global...
 
WHO European Action Plan for the Prevention and Control of Noncommunicable Di...
WHO European Action Plan for the Prevention and Control of Noncommunicable Di...WHO European Action Plan for the Prevention and Control of Noncommunicable Di...
WHO European Action Plan for the Prevention and Control of Noncommunicable Di...
 

More from PonenciesASPCAT

IOGT-NTO.pdf
IOGT-NTO.pdfIOGT-NTO.pdf
IOGT-NTO.pdf
PonenciesASPCAT
 
APN_Sheila Gilheany.pdf
APN_Sheila Gilheany.pdfAPN_Sheila Gilheany.pdf
APN_Sheila Gilheany.pdf
PonenciesASPCAT
 
APN_Jim McCambridge.pdf
APN_Jim McCambridge.pdfAPN_Jim McCambridge.pdf
APN_Jim McCambridge.pdf
PonenciesASPCAT
 
APN EVIN LAW GALLOPEL.pdf
APN EVIN LAW GALLOPEL.pdfAPN EVIN LAW GALLOPEL.pdf
APN EVIN LAW GALLOPEL.pdf
PonenciesASPCAT
 
APN _CiaraGilmartin.pdf
APN _CiaraGilmartin.pdfAPN _CiaraGilmartin.pdf
APN _CiaraGilmartin.pdf
PonenciesASPCAT
 
Mesa_3.1_Panorama_Europeo_I.Indave.pdf
Mesa_3.1_Panorama_Europeo_I.Indave.pdfMesa_3.1_Panorama_Europeo_I.Indave.pdf
Mesa_3.1_Panorama_Europeo_I.Indave.pdf
PonenciesASPCAT
 
Mesa 3.3_ErinOMara_speech.pdf
Mesa 3.3_ErinOMara_speech.pdfMesa 3.3_ErinOMara_speech.pdf
Mesa 3.3_ErinOMara_speech.pdf
PonenciesASPCAT
 
Mesa 3.3_ErinMara_present_controlvsemmanc.pdf
Mesa 3.3_ErinMara_present_controlvsemmanc.pdfMesa 3.3_ErinMara_present_controlvsemmanc.pdf
Mesa 3.3_ErinMara_present_controlvsemmanc.pdf
PonenciesASPCAT
 
Guia butxaca UBA adults.pdf
Guia butxaca UBA adults.pdfGuia butxaca UBA adults.pdf
Guia butxaca UBA adults.pdf
PonenciesASPCAT
 
Manual de registre de dades al ECAP.pdf
Manual de registre de dades al ECAP.pdfManual de registre de dades al ECAP.pdf
Manual de registre de dades al ECAP.pdf
PonenciesASPCAT
 
Guia de Pràctica Clínica Alcohol menors joves i famílies.pdf
Guia de Pràctica Clínica Alcohol menors joves i famílies.pdfGuia de Pràctica Clínica Alcohol menors joves i famílies.pdf
Guia de Pràctica Clínica Alcohol menors joves i famílies.pdf
PonenciesASPCAT
 
Guia butxaca pediatria.pdf
Guia butxaca pediatria.pdfGuia butxaca pediatria.pdf
Guia butxaca pediatria.pdf
PonenciesASPCAT
 
4.Registre primària.pdf
4.Registre primària.pdf4.Registre primària.pdf
4.Registre primària.pdf
PonenciesASPCAT
 
3. Atenció primària.pdf
3. Atenció primària.pdf3. Atenció primària.pdf
3. Atenció primària.pdf
PonenciesASPCAT
 
2.Urgencies.pdf
2.Urgencies.pdf2.Urgencies.pdf
2.Urgencies.pdf
PonenciesASPCAT
 
1.Introducció.pdf
1.Introducció.pdf1.Introducció.pdf
1.Introducció.pdf
PonenciesASPCAT
 
Mesa_3.4. Experiencia_Vancouver_K.Lock.pdf
Mesa_3.4. Experiencia_Vancouver_K.Lock.pdfMesa_3.4. Experiencia_Vancouver_K.Lock.pdf
Mesa_3.4. Experiencia_Vancouver_K.Lock.pdf
PonenciesASPCAT
 
Mesa_3.2. Aspectos cl”nicos en el tratamiento asistido con hero”na. La experi...
Mesa_3.2. Aspectos cl”nicos en el tratamiento asistido con hero”na. La experi...Mesa_3.2. Aspectos cl”nicos en el tratamiento asistido con hero”na. La experi...
Mesa_3.2. Aspectos cl”nicos en el tratamiento asistido con hero”na. La experi...
PonenciesASPCAT
 
Mesa_3.1_Panorama_Europeo_I.Indave.pdf
Mesa_3.1_Panorama_Europeo_I.Indave.pdfMesa_3.1_Panorama_Europeo_I.Indave.pdf
Mesa_3.1_Panorama_Europeo_I.Indave.pdf
PonenciesASPCAT
 
Mesa_2.3_Aspectos_legales_M.Rodriguez_AEMPS.pdf
Mesa_2.3_Aspectos_legales_M.Rodriguez_AEMPS.pdfMesa_2.3_Aspectos_legales_M.Rodriguez_AEMPS.pdf
Mesa_2.3_Aspectos_legales_M.Rodriguez_AEMPS.pdf
PonenciesASPCAT
 

More from PonenciesASPCAT (20)

IOGT-NTO.pdf
IOGT-NTO.pdfIOGT-NTO.pdf
IOGT-NTO.pdf
 
APN_Sheila Gilheany.pdf
APN_Sheila Gilheany.pdfAPN_Sheila Gilheany.pdf
APN_Sheila Gilheany.pdf
 
APN_Jim McCambridge.pdf
APN_Jim McCambridge.pdfAPN_Jim McCambridge.pdf
APN_Jim McCambridge.pdf
 
APN EVIN LAW GALLOPEL.pdf
APN EVIN LAW GALLOPEL.pdfAPN EVIN LAW GALLOPEL.pdf
APN EVIN LAW GALLOPEL.pdf
 
APN _CiaraGilmartin.pdf
APN _CiaraGilmartin.pdfAPN _CiaraGilmartin.pdf
APN _CiaraGilmartin.pdf
 
Mesa_3.1_Panorama_Europeo_I.Indave.pdf
Mesa_3.1_Panorama_Europeo_I.Indave.pdfMesa_3.1_Panorama_Europeo_I.Indave.pdf
Mesa_3.1_Panorama_Europeo_I.Indave.pdf
 
Mesa 3.3_ErinOMara_speech.pdf
Mesa 3.3_ErinOMara_speech.pdfMesa 3.3_ErinOMara_speech.pdf
Mesa 3.3_ErinOMara_speech.pdf
 
Mesa 3.3_ErinMara_present_controlvsemmanc.pdf
Mesa 3.3_ErinMara_present_controlvsemmanc.pdfMesa 3.3_ErinMara_present_controlvsemmanc.pdf
Mesa 3.3_ErinMara_present_controlvsemmanc.pdf
 
Guia butxaca UBA adults.pdf
Guia butxaca UBA adults.pdfGuia butxaca UBA adults.pdf
Guia butxaca UBA adults.pdf
 
Manual de registre de dades al ECAP.pdf
Manual de registre de dades al ECAP.pdfManual de registre de dades al ECAP.pdf
Manual de registre de dades al ECAP.pdf
 
Guia de Pràctica Clínica Alcohol menors joves i famílies.pdf
Guia de Pràctica Clínica Alcohol menors joves i famílies.pdfGuia de Pràctica Clínica Alcohol menors joves i famílies.pdf
Guia de Pràctica Clínica Alcohol menors joves i famílies.pdf
 
Guia butxaca pediatria.pdf
Guia butxaca pediatria.pdfGuia butxaca pediatria.pdf
Guia butxaca pediatria.pdf
 
4.Registre primària.pdf
4.Registre primària.pdf4.Registre primària.pdf
4.Registre primària.pdf
 
3. Atenció primària.pdf
3. Atenció primària.pdf3. Atenció primària.pdf
3. Atenció primària.pdf
 
2.Urgencies.pdf
2.Urgencies.pdf2.Urgencies.pdf
2.Urgencies.pdf
 
1.Introducció.pdf
1.Introducció.pdf1.Introducció.pdf
1.Introducció.pdf
 
Mesa_3.4. Experiencia_Vancouver_K.Lock.pdf
Mesa_3.4. Experiencia_Vancouver_K.Lock.pdfMesa_3.4. Experiencia_Vancouver_K.Lock.pdf
Mesa_3.4. Experiencia_Vancouver_K.Lock.pdf
 
Mesa_3.2. Aspectos cl”nicos en el tratamiento asistido con hero”na. La experi...
Mesa_3.2. Aspectos cl”nicos en el tratamiento asistido con hero”na. La experi...Mesa_3.2. Aspectos cl”nicos en el tratamiento asistido con hero”na. La experi...
Mesa_3.2. Aspectos cl”nicos en el tratamiento asistido con hero”na. La experi...
 
Mesa_3.1_Panorama_Europeo_I.Indave.pdf
Mesa_3.1_Panorama_Europeo_I.Indave.pdfMesa_3.1_Panorama_Europeo_I.Indave.pdf
Mesa_3.1_Panorama_Europeo_I.Indave.pdf
 
Mesa_2.3_Aspectos_legales_M.Rodriguez_AEMPS.pdf
Mesa_2.3_Aspectos_legales_M.Rodriguez_AEMPS.pdfMesa_2.3_Aspectos_legales_M.Rodriguez_AEMPS.pdf
Mesa_2.3_Aspectos_legales_M.Rodriguez_AEMPS.pdf
 

Recently uploaded

PCF-Assessment-Tool_Policy-Guide (1).pdf
PCF-Assessment-Tool_Policy-Guide (1).pdfPCF-Assessment-Tool_Policy-Guide (1).pdf
PCF-Assessment-Tool_Policy-Guide (1).pdf
AbHermoso
 
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
CarriePoppy
 
Approach to Head Injuiry, Intracranial Pressure Measurement and Management.pptx
Approach to Head Injuiry, Intracranial Pressure Measurement and Management.pptxApproach to Head Injuiry, Intracranial Pressure Measurement and Management.pptx
Approach to Head Injuiry, Intracranial Pressure Measurement and Management.pptx
Bipul Thakur
 
anthelmintic-drugs.pptx pharmacology dep
anthelmintic-drugs.pptx pharmacology depanthelmintic-drugs.pptx pharmacology dep
anthelmintic-drugs.pptx pharmacology dep
sapnasirswal
 
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
FFragrant
 
Hand Book of Oncology Nursing - Cancer Nursing Book
Hand Book of Oncology Nursing - Cancer Nursing BookHand Book of Oncology Nursing - Cancer Nursing Book
Hand Book of Oncology Nursing - Cancer Nursing Book
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
DRPREETHIJAMESP
 
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
Sarthi Life Sciences
 
Text Book of Critical Care Nursing ICU NURSING
Text Book of Critical Care Nursing  ICU NURSINGText Book of Critical Care Nursing  ICU NURSING
Text Book of Critical Care Nursing ICU NURSING
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
Niranjan Chavan
 
BCBR MCQs with Answers.pdf for exam for NMC promotions
BCBR MCQs with Answers.pdf for exam for NMC promotionsBCBR MCQs with Answers.pdf for exam for NMC promotions
BCBR MCQs with Answers.pdf for exam for NMC promotions
sathya swaroop patnaik
 
MEDICAL PROFESSIONALISM Class of compassionate care
MEDICAL PROFESSIONALISM Class of compassionate careMEDICAL PROFESSIONALISM Class of compassionate care
MEDICAL PROFESSIONALISM Class of compassionate care
Debre Berhan University
 
Care and Maintenance of Laboratory Equipment in Histotechnology.pptx
Care and Maintenance of Laboratory Equipment in Histotechnology.pptxCare and Maintenance of Laboratory Equipment in Histotechnology.pptx
Care and Maintenance of Laboratory Equipment in Histotechnology.pptx
Dr. Jagroop Singh
 
FUNCTIONAL DYSPEPSIA by Dr. Maryam Iqbal
FUNCTIONAL DYSPEPSIA by Dr. Maryam IqbalFUNCTIONAL DYSPEPSIA by Dr. Maryam Iqbal
FUNCTIONAL DYSPEPSIA by Dr. Maryam Iqbal
Zain Umar
 
2nd week of Human development .embryology
2nd week of Human development .embryology2nd week of Human development .embryology
2nd week of Human development .embryology
Mithilesh Chaurasia
 
Article - Design and evaluation of novel inhibitors for the treatment of clea...
Article - Design and evaluation of novel inhibitors for the treatment of clea...Article - Design and evaluation of novel inhibitors for the treatment of clea...
Article - Design and evaluation of novel inhibitors for the treatment of clea...
Trustlife
 
SA Gastro Cure(pancreatic cancer treatment in india).pptx
SA Gastro Cure(pancreatic cancer treatment in india).pptxSA Gastro Cure(pancreatic cancer treatment in india).pptx
SA Gastro Cure(pancreatic cancer treatment in india).pptx
VinothKumar70905
 
GAIRIKA.pptx for Rasashastra and Bhaisajya kalpana
GAIRIKA.pptx for Rasashastra and Bhaisajya kalpanaGAIRIKA.pptx for Rasashastra and Bhaisajya kalpana
GAIRIKA.pptx for Rasashastra and Bhaisajya kalpana
AparnaNandakumar12
 
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdfNUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
MatsikoAlex
 
symblephoron types etiology management.pptx
symblephoron types etiology management.pptxsymblephoron types etiology management.pptx
symblephoron types etiology management.pptx
mohammadsumairah
 

Recently uploaded (20)

PCF-Assessment-Tool_Policy-Guide (1).pdf
PCF-Assessment-Tool_Policy-Guide (1).pdfPCF-Assessment-Tool_Policy-Guide (1).pdf
PCF-Assessment-Tool_Policy-Guide (1).pdf
 
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
 
Approach to Head Injuiry, Intracranial Pressure Measurement and Management.pptx
Approach to Head Injuiry, Intracranial Pressure Measurement and Management.pptxApproach to Head Injuiry, Intracranial Pressure Measurement and Management.pptx
Approach to Head Injuiry, Intracranial Pressure Measurement and Management.pptx
 
anthelmintic-drugs.pptx pharmacology dep
anthelmintic-drugs.pptx pharmacology depanthelmintic-drugs.pptx pharmacology dep
anthelmintic-drugs.pptx pharmacology dep
 
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
Safeguarding Reproductive Health- Preventing Fallopian Tube Blockage After a ...
 
Hand Book of Oncology Nursing - Cancer Nursing Book
Hand Book of Oncology Nursing - Cancer Nursing BookHand Book of Oncology Nursing - Cancer Nursing Book
Hand Book of Oncology Nursing - Cancer Nursing Book
 
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
THE REVIEW OF THE ENCYCLOPEDIA OF PURE MATERIA MEDICA.BHMS.MATERIA MEDICA.HOM...
 
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
PCD Pharma Franchise For Gynae Products | Infertility Range - Sarthi Life Sci...
 
Text Book of Critical Care Nursing ICU NURSING
Text Book of Critical Care Nursing  ICU NURSINGText Book of Critical Care Nursing  ICU NURSING
Text Book of Critical Care Nursing ICU NURSING
 
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
 
BCBR MCQs with Answers.pdf for exam for NMC promotions
BCBR MCQs with Answers.pdf for exam for NMC promotionsBCBR MCQs with Answers.pdf for exam for NMC promotions
BCBR MCQs with Answers.pdf for exam for NMC promotions
 
MEDICAL PROFESSIONALISM Class of compassionate care
MEDICAL PROFESSIONALISM Class of compassionate careMEDICAL PROFESSIONALISM Class of compassionate care
MEDICAL PROFESSIONALISM Class of compassionate care
 
Care and Maintenance of Laboratory Equipment in Histotechnology.pptx
Care and Maintenance of Laboratory Equipment in Histotechnology.pptxCare and Maintenance of Laboratory Equipment in Histotechnology.pptx
Care and Maintenance of Laboratory Equipment in Histotechnology.pptx
 
FUNCTIONAL DYSPEPSIA by Dr. Maryam Iqbal
FUNCTIONAL DYSPEPSIA by Dr. Maryam IqbalFUNCTIONAL DYSPEPSIA by Dr. Maryam Iqbal
FUNCTIONAL DYSPEPSIA by Dr. Maryam Iqbal
 
2nd week of Human development .embryology
2nd week of Human development .embryology2nd week of Human development .embryology
2nd week of Human development .embryology
 
Article - Design and evaluation of novel inhibitors for the treatment of clea...
Article - Design and evaluation of novel inhibitors for the treatment of clea...Article - Design and evaluation of novel inhibitors for the treatment of clea...
Article - Design and evaluation of novel inhibitors for the treatment of clea...
 
SA Gastro Cure(pancreatic cancer treatment in india).pptx
SA Gastro Cure(pancreatic cancer treatment in india).pptxSA Gastro Cure(pancreatic cancer treatment in india).pptx
SA Gastro Cure(pancreatic cancer treatment in india).pptx
 
GAIRIKA.pptx for Rasashastra and Bhaisajya kalpana
GAIRIKA.pptx for Rasashastra and Bhaisajya kalpanaGAIRIKA.pptx for Rasashastra and Bhaisajya kalpana
GAIRIKA.pptx for Rasashastra and Bhaisajya kalpana
 
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdfNUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
 
symblephoron types etiology management.pptx
symblephoron types etiology management.pptxsymblephoron types etiology management.pptx
symblephoron types etiology management.pptx
 

EC APN 22 6 23.pdf

  • 1. Alcohol Policy Network in Europe (APN) Symposium, 22nd June 2023, Vilnius, Lithuania WHO/EU Evidence into Action Alcohol Project (EVID-ACTION): Update Dr Eric Carlin, WHO Regional Office for Europe
  • 2. • Focus on reducing alcohol consumption and harms • Includes 10% APC reduction by 2025, with at least 35 Member States being below baseline of 2010.
  • 3. There is no safe level of alcohol consumption for cancer risk Half of all alcohol- attributable cancers are NOT because of heavy drinking + so is the majority of breast cancers. 3
  • 4. WHO/EU Evidence into Action Alcohol Project (EVID-ACTION)
  • 5. Source: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/total-(recorded-unrecorded)-alcohol-per-capita-(15-)-consumption (2019 data) 0,0 2,0 4,0 6,0 8,0 10,0 12,0 14,0 16,0 18,0 W o r l d N o r w a y G r e e c e I t a l y C y p r u s I c e l a n d M a l t a C r o a t i a U k r a i n e F i n l a n d W H O E u r o p e r e g i o n S w e d e n N e t h e r l a n d s D e n m a r k B e l g i u m P o r t u g a l S l o v a k i a H u n g a r y S p a i n E U 2 7 S l o v e n i a E s t o n i a F r a n c e L u x e m b o u r g P o l a n d I r e l a n d L i t h u a n i a B u l g a r i a A u s t r i a G e r m a n y L a t v i a C z e c h i a R o m a n i a Annually, every adult (15+) in the EU drinks 11 litres of pure alcohol Out of the top 10 countries with highest drinking levels: 7 are in the EU
  • 6. Source: Source: own calculations, based on Rumgay et al., 2021; Sung et al., 2021. Alcohol-attributable cancer cases (lighter colours) and deaths (darker colours) in the EU, by sex and cancer type, 2020. Alcohol-attributable cancer cases and deaths in the EU In the EU, 3 out of 10 deaths from alcohol- attributable causes were due to alcohol- attributable cancers (2019 data).
  • 7. Official launch of WHO/EU Evidence into Action Alcohol Project (EVID-ACTION) and meeting of EVID-ACTION Focal Point Network on Alcohol 6 – 7 December 2022, Copenhagen
  • 9. Alcohol Health Warnings Capacity Building, Health Literacy, Public Knowledge and Advocacy Screening and Brief Interventions Evidence and Tools for Action WHO EU Member States’ Focal point on Alcohol Alcohol Action Networks Training Alcohol Health Warnings Screening and Brief interventions Public information EU Member States, Iceland, Norway and Ukraine WHO/EU Evidence into Action Alcohol Project (EVID-ACTION)
  • 10. WHO/EU Evidence into Action Alcohol Project (EVID-ACTION): Expected results a) Improved technical capabilities Higher levels of awareness Increased support for evidence- based policies b) Training packages on implementation of brief interventions c) Strengthened capacity to apply innovative methods in alcohol health promotion activities
  • 11. Specific objective (SO) one: Health warnings Develop the evidence base on alcohol health warnings, with a specific focus on cancer risks, to inform the design and development and implementation of impactful alcohol health warnings.
  • 12. SO1: Alcohol health warnings: Activities to date & planned Establishment of Technical Advisory Group (TAG) 20 experts worldwide, 1st meeting Dec 2022, 2nd, online meeting Feb and March 2023, next meeting planned Q3 2023 Establishing working groups in the TAG, e.g. working group on legal experts Experiments Online experiment investigating impact of (cancer) warnings on attention, knowledge, risk perceptions and intentions. Dissemination in 14 EU countries, 19000+ responses First protocol draft of an exploratory eye-tracking study on the impact of label design on attention Co-creation workshops Pilot workshops in Ireland in Dec 2022, involving different population groups Further consultations in association with the established networks Real-world studies Pilot study with WHO CC in Barcelona: point of sale labels with general health harm message and QR code to investigate number of shoppers using it to look for the information online Establishment of collaboration initiative with Nordic countries for further studies on impact of health messages and QR code use in Nordic monopolies Publications Producing draft report describing findings of the online experiment and pilot studies Producing several peer-reviewed articles based on the conducted reviews and the experimental evidence
  • 14. What is the reach of QR codes as sources of product information for alcoholic beverages? Pilot study: Barcelona Setting: Supermarket Information via: Point of sale Information components: “Alcohol harms your health” For more information see QR code Result: Less than 1 per mille of paying costumers assessed website via QR code Conclusion: Providing QR via point of sale will likely not lead to high reach of consumers Source: Rehm et al., 2023 https://onlinelibrary.wiley.com/doi/10.1111/dar.13676
  • 15. Specific objective (SO) two: Capacity building, Health literacy, public knowledge and advocacy • Strengthening expertise and sharing of experience • Supporting Member States’ resilience in protecting public health interests in relation to alcohol policies • National and transnational regulatory collaboration • Public communications about alcohol consumption and cancer risks and policy options.
  • 16. Training session for EVID-ACTION Member states on how to recognize and manage Conflicts of Interest, Copenhagen, 7th December 2022 Professor Jeff Collin, Professor of Global Health Policy, Global Health Policy Unit, University of Edinburgh Dr Nason Maani, Lecturer in Inequalities and Global Health Policy, Global Health Policy Unit, University of Edinburgh
  • 17. WHO/EU Evidence into Action Alcohol Project (EVID-ACTION) Early career researcher seminar on alcohol and public health, Tallinn, 14-15 May 2023
  • 21. Training session for EVID-ACTION Member States representatives in alcohol epidemiology: what are the key indicators and how to collect and manage these? Tallinn, 18 May 2023
  • 26. Specific objective (SO) three Screening and Brief Interventions (SBIs) • Provide technical tools and training to support implementation of evidence-based screening and brief interventions in: • Primary healthcare • Workplace • Social services • Assess and map existing resources and tools
  • 27. Intercountry expert consultation on brief interventions (BRIEF), Barcelona, 24th – 26th April 2023
  • 28. 1) Raising EU visibility and promoting the collaboration of WHO and the EU 2) Raising Awareness 3) Changing perceptions Target audiences Communications Objectives Project partners Decision makers Narrative shapers EU, DG Sante, WHO HQ, UN Organizations, NGOs Member States, health, social protection, finance ministries, policy advisors in government civil society organizations, youth organizations, academics; health system stakeholders, country experts, public health influencers and influential media. Clear and comprehensive messages targeted at the general public and tailored to:
  • 29. WHO/EU Evidence into Action Alcohol Project (EVID-ACTION) ‘Disrupting narratives on alcohol’: Expert workshop on communications Copenhagen, 30th March 2023
  • 31. Some of the planned activities coming up later in 2023: Vilnius: 22nd June, Alcohol Policy Network 23rd June, EUCAM Digital Marketing Conference 24th June WHO Expert meeting on Alcohol Digital Marketing also with support of Government of Netherlands) Barcelona: 11th – 13th September, Research conference, including Early Career Researchers meeting Brussels: 7th – 8th October, 1st Meeting EVID-ACTION Youth Network 9th – 10th October, EVID-ACTION Member States Focal Point meeting 11th October, Launch of WHO Alcohol Playbook November: Activities related to European Awareness Week on Alcohol- Related harms